These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 11424782)
1. Timing of exogenous surfactant administration in clinical practice. Report of a multi-center Italian Observational Study. Bevilacqua G Acta Biomed Ateneo Parmense; 2000; 71 Suppl 1():421-9. PubMed ID: 11424782 [TBL] [Abstract][Full Text] [Related]
2. Use of surfactant for prophylaxis versus rescue treatment of respiratory distress syndrome: experience from an Italian-Bulgarian trial. Bevilacqua G; Chernev T; Parmigiani S; Iarakova N; Gaioni L; Volante E; Gambini L; Bussolati G Acta Biomed Ateneo Parmense; 1997; 68 Suppl 1():47-54. PubMed ID: 10021717 [TBL] [Abstract][Full Text] [Related]
3. Use of surfactant for prevention of respiratory distress syndrome in newborn infants in spontaneous breathing. A randomized multicentre clinical pilot-study. Dambeanu JM; Parmigiani S; Marinescu B; Bevilacqua G Acta Biomed Ateneo Parmense; 1997; 68 Suppl 1():39-45. PubMed ID: 10021716 [TBL] [Abstract][Full Text] [Related]
4. Evolution of respiratory mechanics in preterm babies after surfactant administration in the neonatal period. Parmigiani S; Panza C; Bevilacqua G Acta Biomed Ateneo Parmense; 1997; 68 Suppl 1():65-73. PubMed ID: 10021719 [TBL] [Abstract][Full Text] [Related]
5. Bovine surfactant replacement therapy in neonates of less than 30 weeks' gestation: a randomized controlled trial of prophylaxis versus treatment. Dunn MS; Shennan AT; Zayack D; Possmayer F Pediatrics; 1991 Mar; 87(3):377-86. PubMed ID: 2000278 [TBL] [Abstract][Full Text] [Related]
6. An observational study of surfactant treatment in infants of 23-30 weeks' gestation: comparison of prophylaxis and early rescue. Bevilacqua G; Parmigiani S; J Matern Fetal Neonatal Med; 2003 Sep; 14(3):197-204. PubMed ID: 14694975 [TBL] [Abstract][Full Text] [Related]
7. Surfactant replacement therapy with a single postventilatory dose of a reconstituted bovine surfactant in preterm neonates with respiratory distress syndrome: final analysis of a multicenter, double-blind, randomized trial and comparison with similar trials. The Surfactant-TA Study Group. Fujiwara T; Konishi M; Chida S; Okuyama K; Ogawa Y; Takeuchi Y; Nishida H; Kito H; Fujimura M; Nakamura H Pediatrics; 1990 Nov; 86(5):753-64. PubMed ID: 2235230 [TBL] [Abstract][Full Text] [Related]
8. [Use and efficacy of treatment with porcine surfactant in newborns with birth weight < or = 1000 g: experience in 3 years]. Brusamento S; Buffo M; Carnielli VP Pediatr Med Chir; 1999; 21(6):261-5. PubMed ID: 11293146 [TBL] [Abstract][Full Text] [Related]
9. Repeat surfactant therapy for postsurfactant slump. Katz LA; Klein JM J Perinatol; 2006 Jul; 26(7):414-22. PubMed ID: 16724122 [TBL] [Abstract][Full Text] [Related]
10. Prophylactic administration of calf lung surfactant extract is more effective than early treatment of respiratory distress syndrome in neonates of 29 through 32 weeks' gestation. Kattwinkel J; Bloom BT; Delmore P; Davis CL; Farrell E; Friss H; Jung AL; King K; Mueller D Pediatrics; 1993 Jul; 92(1):90-8. PubMed ID: 8516091 [TBL] [Abstract][Full Text] [Related]
11. A multicenter randomized, placebo-controlled trial of surfactant therapy for respiratory distress syndrome. Horbar JD; Soll RF; Sutherland JM; Kotagal U; Philip AG; Kessler DL; Little GA; Edwards WH; Vidyasagar D; Raju TN N Engl J Med; 1989 Apr; 320(15):959-65. PubMed ID: 2648150 [TBL] [Abstract][Full Text] [Related]
12. Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome. Ross Collaborative Surfactant Prevention Study Group. Soll RF; Hoekstra RE; Fangman JJ; Corbet AJ; Adams JM; James LS; Schulze K; Oh W; Roberts JD; Dorst JP Pediatrics; 1990 Jun; 85(6):1092-102. PubMed ID: 2187176 [TBL] [Abstract][Full Text] [Related]
13. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group. Long W; Corbet A; Cotton R; Courtney S; McGuiness G; Walter D; Watts J; Smyth J; Bard H; Chernick V N Engl J Med; 1991 Dec; 325(24):1696-703. PubMed ID: 1944470 [TBL] [Abstract][Full Text] [Related]
14. [Effect from surfactant therapy in extremely low birth weight infants depending on the method of delivery]. Iarŭkova N; Nikolov A; Slŭncheva B; Vakrilova L; Pramatarova T; Dimitrov A Akush Ginekol (Sofiia); 2007; 46(3):31-5. PubMed ID: 18018780 [TBL] [Abstract][Full Text] [Related]
16. [Treatment of neonatal respiratory distress syndrome with Alveofact--results of a prospective observational study]. Wauer RR; Schmalisch G; Rogalski M Klin Padiatr; 1996; 208(6):355-65. PubMed ID: 9064378 [TBL] [Abstract][Full Text] [Related]
17. Comparison outcomes of surfactant therapy in respiratory distress syndrome in two periods. Chotigeat U; Promwong N; Kanjanapattanakul W; Khorana M; Sangtawesin V; Horpaopan S J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S109-14. PubMed ID: 19253505 [TBL] [Abstract][Full Text] [Related]
18. Observational study to compare the clinical efficacy of the natural surfactants Alveofact and Curosurf in the treatment of respiratory distress syndrome in premature infants. Proquitté H; Dushe T; Hammer H; Rüdiger M; Schmalisch G; Wauer RR Respir Med; 2007 Jan; 101(1):169-76. PubMed ID: 16698258 [TBL] [Abstract][Full Text] [Related]
19. [Comparison of the early response to natural and synthetic surfactant in premature babies with respiratory distress syndrome]. Rutkowska M Med Wieku Rozwoj; 2000; 4(2 Suppl 3):29-42. PubMed ID: 11328968 [TBL] [Abstract][Full Text] [Related]
20. Comparison of prophylaxis and rescue treatment with Curosurf in neonates less than 30 weeks' gestation: a randomized trial. Egberts J; de Winter JP; Sedin G; de Kleine MJ; Broberger U; van Bel F; Curstedt T; Robertson B Pediatrics; 1993 Dec; 92(6):768-74. PubMed ID: 8233735 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]